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TVAAssessing the molecular control of development and cell fate in individual cells in the intact mammary
epithelium has not been possible to date. By exploiting an intraductal retrovirus (RCAS)-mediated gene
delivery method to introduce a marker gene, we found that ductal epithelial cells are turned over with a half
time of approximately 1 month in adult virgin mice. However, following RCAS-mediated introduction of a
constitutively activated STAT5a (caSTAT5a), caSTAT5a-activated ductal epithelial cells expand and replace
other cells in the epithelium, eventually forming a mammary gland resembling that in a late pregnant
mouse, suggesting that STAT5a activation alone is sufﬁcient to mediate pregnancy-induced mammary cell
expansion, alveolar cell fate commitment, and lactogenesis. Furthermore, such caSTAT5a-induced alveolar
differentiation does not require ovarian functions, although caSTAT5a-induced cell proliferation is partly
reduced in ovariectomized mice. In conclusion, in this ﬁrst report of studying the developmental role of a
gene in a few cells in a normally developed virgin mammary ductal tree, STAT5a activation causes alveolar
fate commitment and lactogenesis, and with the help of ovarian hormones, drives alveolar expansion.ast Center, Baylor College of
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Themammary ductal tree in amature virginmouse is composed of
an inner layer of epithelial cells and an outer layer of myoepithelial
cells. Under the inﬂuence of ovarian hormones, a low level of
proliferation–less than 5%–is maintained to replenish cells that die
off (Clarke et al., 1997; Yi et al., 2004). However, the exact cell
turnover rate of the ductal epithelial cells in a mammary gland is not
known. Commonly available genetic approaches including knockout
and transgenic models usually are not appropriate for answering this
question, since individual cells usually cannot be traced (Fata et al.,
2001; Rose-Hellekant et al., 2006). Consequently, it is also not known
what regulates the rate of epithelial cell turnover in the mammary
gland.
During pregnancy, this relatively quiescent mammary epithelium
undergoes rapid expansion and differentiation, forming densely
populated lobuloalveoli. Many transcription factors are known to be
required for mammary cell proliferation and alveolar differentiation
(Grimm et al., 2002). One of the best studied of these is STAT5a, amember of the signal transducer and activator of transcription (STAT)
family of transcription factors (Hennighausen and Robinson, 2008;
Watson and Neoh, 2008). In the mammary gland, STAT5a is activated
primarily by prolactin binding to its cognate receptor, while STAT5b is
activated primarily by growth hormone (GH) (Teglund et al., 1998;
Udy et al., 1997). In knockout mouse studies, STAT5a was found to be
required for alveologenesis and alveolar progenitor cell survival (Liu
et al., 1997; Miyoshi et al., 2001; Yamaji et al., 2009). Ablation of Elf5,
both a transcriptional target of STAT5a and a transcriptional activator
of the STAT5a gene, resulted in loss of lobuloalveolar structures (Choi
et al., 2009; Oakes et al., 2008). In support of the essential role of
STAT5a in alveologenesis, a constitutively active STAT5a-Gyrase B
fusion protein has been reported to induce genes encoding casein and
whey-acidic protein (WAP) in a cultured cell line (KIM-2) (Clarkson
et al., 2006). Furthermore, transgenic expression of wild-type STAT5a
or a constitutively active variant of STAT5a was found to promote
differentiation during pregnancy (Iavnilovitch et al., 2002).
We have recently reported the adaptation of a retrovirus gene
delivery method for genetic manipulation of individual ductal
epithelial cells in an intact mammary gland (Du et al., 2006). In this
system, an expression vector (RCAS) modiﬁed from avian retrovirus
subgroup A is used to stably integrate a gene of interest (GOI) into the
chromosomes of cells in a mouse line (MMTV-tva) that are made
susceptible to RCAS infection by transgenic expression of the gene
Fig. 1. STAT5a activation inﬂuences mammary epithelial cell turnover. (A) Twelve-
week-oldMMTV-tvamice (n=15)were infected with RCAS-β-actin(HA) in the left #2–
4 glands, and RCAS-caSTAT5a(FLAG) in the contralateral glands. Five mice each were
euthanized at days 4, 14, and 31 post-infection. Infected cells were detected by
immunohistochemical staining for the HA or FLAG tag. (B) The numbers of infected cells
per cm2 of a section were determined by counting at least 3–5 sections per mouse, and
were plotted in logarithmic scale. The p values for changes from day 14 to day 31 in the
β-actin and caSTAT5a groups were 0.02 and 0.003, respectively. The p value for the two
groups at day 31 was 1.7e-05. (C) The percentages of TUNEL positive cells were
determined by counting at least ﬁve infected ducts per section, plotted as a bar graph.
p=0.8e-03, N=3 mice per group.
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cells, proviral RCAS does not produce any detectable amounts of viral
gene products other than the GOI. Since the virus is delivered
intraductally, ex vivo infection and transplantation are not necessary,
eliminating the complications associated with ex vivo manipulations
and loss of mammary structural integrity. Using this approach, we
examined the rate of mammary ductal epithelial cell turnover, and
studied the impact of STAT5a activation on the turnover rate and the
cell fate in the absence of a pregnancy or any ovarian hormone.
Results
Mammary epithelial cells in an adult virgin exhibit a slow turnover
Intraductal injection of 107 IUs of RCAS-GFP into 12-week-old
virgin MMTV-tva mice led to an infection rate of 0.25±0.08%
mammary cells per gland (Toneff et al., unpublished). In order to
estimate the cell turnover rate of mammary ductal epithelial cells
tagged by RCAS, here we chose to use a virus that makes an
endogenous protein to avoid any toxicity or immune response that
may associate with the expression of GFP. We created a reporter RCAS
virus expressing murine β-actin tagged by a single HA epitope. (The
HA tag encoded by RCAS vectors does not elicit any detectable
immune response in themammary gland (Du et al., 2006; Reddy et al.,
2010; Siwko et al., 2008).) We injected this virus (approximately 107
IUs per gland; 3 glands per mouse) intraductally into 15 MMTV-tva
mice at 12 weeks of age, and euthanized 5 infected mice each at days
4, 14, and 31. Using immunohistochemical staining for the HA epitope,
we surveyed the number of infected cells in 10 sections across the
depth of the entire mammary gland. As expected, infected cells were
predominantly luminal (Fig. 1A). (Only 0.4±0.2% of positively stained
cells expressed the keratin 5 basal cell marker at day 4 post infection
[Toneff et al, unpublished]). While the number of positively stained
cells changed very little from days 4 to 14, it decreased by
approximately 50% by day 31 (Fig. 1B). Altogether, these data suggest
that mammary epithelial cells in adult virgins turn over relatively
slowly, with a half life of approximately 30 days. The loss of these
virus-tagged cells is most likely due to apoptosis, since 2.1±0.1% of
cells of the infected ducts were TUNEL positive (n=3 mice) (Fig. 1C).
A constitutively activated mutant of STAT5a expands the mammary cell
population
To examine whether STAT5a activation is sufﬁcient to cause
mammary cell expansion, we ﬁrst cloned a FLAG-tagged constitutively
activated version of murine STAT5a into the RCAS vector (Supplemental
ﬁgure 1A). Forty-eight hours after transfecting this vector (RCAS-
caSTAT5a) into the DF1 chicken ﬁbroblast producer line, we collected
the cell lysates and validated by western blotting that caSTAT5a(FLAG)
was produced as an intact protein (Supplemental ﬁgure 1B), and by
immunoﬂuorescence staining that caSTAT5a(FLAG)was localized to the
nucleus (Supplemental ﬁgure 1C). Furthermore, by injecting the
resulting viral particles intraductally into MMTV-tva transgenic mice
and staining the infected glands 4 days later, we conﬁrmed that
caSTAT5a(FLAG) could be detected in the nucleus in a small subset of
mammary luminal epithelial cells (Supplemental ﬁgure 1D).
Using this virus, we infected the contralateral glands of the same
15 mice that we used for infection with RCAS-β-actin(HA), and again
quantiﬁed the number of infected cells at days 4, 14, and 31, in a
manner similar to that described. caSTAT5a(FLAG)-positive cells
expanded by 3.2-fold by day 14 (from 2.5±0.4 cells per CM2 of
a section to 8.2±3.3-cells per CM2), and by 10.9-fold by day 31 (to
27.8±3.3 cells per CM2) (Fig. 1B). These data suggest that STAT5a
activation causes the otherwise relatively quiescent ductal epithelial
cells in virgin mice to undergo rapid expansion. Accordingly, in a
given ductal section that showed evidence of infection (by ﬁnding atleast one positively stained cell), the average number of infected cells
increased by 3.1-fold by day 14 (from 4.3±1.3% to 13.3±1.9%), and
by 9.9-fold by day 31 (to 42.3±4.2%) (Supplemental ﬁgure 2). In
contrast, the average number of RCAS-β-actin(HA)-infected cells per
infected ductal section remained relatively constant by day 14 (from
7.8±1.7% on day 4 to 8.0±1.1% on day 14), and decreased by 44% by
day 31 (to 4.4±1.4%) (Supplemental ﬁgure 2). Moreover, compared
with RCAS-β-actin(HA)-infected cells, RCAS-caSTAT5a(FLAG) infected
cells had a much lower level of apoptosis (0.2±0.2%, p=0.8e-03,
Fig. 1C) at 1 month post infection. These data indicate that STAT5a
activation provides a survival signal for mammary epithelial cells and
198 J. Dong et al. / Developmental Biology 346 (2010) 196–203slows their normal turnover. In addition, caSTAT5a also greatly
stimulated the proliferation of this otherwise relatively quiescent
population of cells, based on immunostaining for Ki67 (Fig. 3C).
STAT5a activation causes ductal epithelial cells in the virgin mammary
epithelium to commit to an alveolar cell fate
Having found that STAT5a activation in virgin mammary epithe-
lium causes rapid cell expansion, we next tested whether STAT5a
activation affected the differentiation of these ductal epithelial cells.
One month following intraductal injection of 12-week-old MMTV-tva
mice (n=5) with RCAS-caSTAT5a(FLAG), clusters of alveoli-like
structures with lipid droplets within cells and in the luminal space
were readily detected in all H&E-stained sections of all injected glands
(3–4 clusters per section) (Fig. 2A). As expected, no alveolar-like
structures were found in the contralateral glands injected with RCAS-
β-actin(HA) (Fig. 2A). To conﬁrm that these alveoli-like foci were
indeed induced by STAT5a activation, we stained these sections forFig. 2. STAT5a activation is sufﬁcient to cause alveologenesis in adult virgin mammary gland
RCAS-β-actin(HA) or RCAS-caSTAT5a(FLAG). One month after infection, the glands were stai
caSTAT5a). Cytoplasmic and secreted lipid droplets are indicated by an arrow and an arrowh
are indicated by an arrow.the FLAG epitope tag. All of these alveoli-like foci were positive for the
FLAG tag (Fig. 2A). In contrast, in sections of mammary glands infected
by RCAS-β-actin(HA), the HA tag was found only in single cells
scattered in the ductal epithelium (Fig. 2A).
To further conﬁrm the differentiation status of these caSTAT5a-
induced alveoli-like structures, we stained them for markers
associated with milk-producing alveolar cells. Adipophilin is specif-
ically localized in cytoplasmic and secreted lipid droplets in
differentiating and lactating mammary glands (McManaman et al.,
2004; Russell et al., 2007). Indeed, all alveolar-like structures and their
associated luminal spaces were positive for adipophilin (ADPH) as
well as β-casein andWAP (Fig. 2B), the predominantmilk proteins. As
expected, glands injected with RCAS-β-actin(HA) did not exhibit any
positive staining for these markers (Fig. 2B). These data indicate that
activated STAT5a alone can induce functional differentiation in
mammary ductal epithelial cells and initiate alveologenesis in the
absence of pregnancy hormones. In addition, Elf5, which is a known
transcriptional target of STAT5a and has been reported to induces. (A) H&E and immunohistochemical staining of mammary glands infected with either
ned by H&E or for the RCAS-encoded protein (HA epitope in β-actin or FLAG epitope in
ead, respectively. (B) Immunostaining for the markers indicated. Secreted lipid droplets
199J. Dong et al. / Developmental Biology 346 (2010) 196–203alveolar differentiation (Harris et al., 2006; Oakes et al., 2008), was
expressed to a greater extent in these alveoli-like structures than in
the control ducts—34.2±3.2% of cells in caSTAT5a-postive structuresFig. 3. STAT5a activation causes alveolar differentiation in ovariectomized mice, and induces
of 12-week-old MMTV-tva virgin mice (n=10) with RCAS-caSTAT5a(FLAG), ovariectomy (O
euthanized for analyses. (A) H&E staining and immunostaining for the FLAG tag in caSTAT5a.
view of the boxed area (Intact) or the infected duct (Ovex). Arrow indicates a milk droplet w
the indicated markers. (C) Immunostaining for Ki67 and quantitation of the percentage ofshowed high staining intensity, while only 4.2±2.4% of cells in β-
actin-positive ducts did (n=4 mice, p=2.4e-07) (Fig. 2B and
Supplemental ﬁgure 3).cell expansion with a partial dependence on ovarian functions. Four days post-infection
vex) or sham surgery was performed, and after another 4 weeks, all infected mice were
The caSTAT5a-postive epithelium is outlined by a dash line. The insets show an enlarged
ithin a cell, and arrowheads indicate milk droplets in the lumen. (B) Immunostaining for
Ki67-positive cells.
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require ovarian function, although caSTAT5a-induced cell proliferation is
partly dependent on reproductive hormones
Reproductive hormones released by ovaries–in particular, estro-
gen and progesterone–are essential for mammary epithelium expan-
sion during several phases ofmammary gland development, including
alveolar bud formation and expansion (Koseki et al., 1987; Lydon et
al., 1995; Muldoon, 1987). In order to test whether the above
observed effects of caSTAT5a are dependent on ovarian hormones, we
intraductally injected ten 12-week-old virgin MMTV-tva mice with
RCAS-caSTAT5a(FLAG), performed ovariectomy or sham surgery
4 days later, and analyzed the infectedmammary glands after another
4 weeks. Ovariectomy prevented the formation of any alveolar
clusters (Fig. 3A); however, lipid droplets and milk proteins were
still readily visible in the cytoplasm and lumen of the ducts that were
found to be positive for the FLAG tag, by H&E and by immunostaining
for adipophilin and β-casein (Fig. 3A and B), althoughWAP expression
was modestly reduced (data not shown). As in intact mice, elevated
Elf5 was also found in the infected ducts in these ovariectomizedmice
(data not shown). These data suggest that caSTAT5a-induced alveolar
differentiation does not require ovarian functions, but that caSTAT5a-
induced cell expansion is at least partially dependent on the
continued presence of reproductive hormones.
To detect any residual proliferative effect of caSTAT5a in the
absence of ovarian hormones, we stained for Ki67 in sections from the
above RCAS-caSTAT5a(FLAG)-infected ovariectomized mice (n=4).
caSTAT5a(FLAG)-positive alveoli contained 9.6±2.5% Ki67-positive
cells, signiﬁcantly higher than the basal level of proliferation (4.1
±0.3%) (Fig. 3C), indicating that STAT5 activation is capable of
inducing mammary cell proliferation in the absence of ovarian
hormones. However, this level of proliferation is signiﬁcantly less
than that observed for caSTAT5a-induced proliferation in intact mice
(24.5±2.1%); thus, ovarian hormones still play a signiﬁcant part in
alveolar expansion stimulated by activated STAT5a. Of note, lower
proliferation in caSTAT5a-positive cells in ovariectomized mice is not
an artifact of reduced caSTAT5a expression: We have reported that
the RCAS LTR is not affected by ovariectomy (Toneff et al., 2010), and
we have conﬁrmed that caSTAT5 was produced at similar levels in
intact vs. ovariectomized infected mice based on staining intensity of
immunohistochemistry and immunoﬂuorescence (Supplemental
ﬁgure 4).
caSTAT5a-activated mammary cells displace other ductal cells in virgin
mice over time to form a mammary gland that resembles a mammary
gland in a late pregnant mouse
Having observed high levels of both proliferation and differenti-
ation in these virgin glands at 1 month following activation of STAT5a,
we next asked whether these scattered foci of alveolar clusters would
regress, as expected for differentiated cells, or would resist the normal
cell turnover and continue to expand with time. To this end, we
infected an additional cohort of MMTV-tva mice (12 weeks old;
n=20) with RCAS-caSTAT5a(FLAG). One year post infection, the
RCAS-caSTAT5a(FLAG)-infected glands appeared white, and harbored
a milk-like liquid (data not shown). By whole mount staining, the
majority of the infected glands were composed entirely of dense
lobuloalveolar structures, resembling a late pregnant gland (Fig. 4A).
Lipid droplets within cytoplasm and in the lumen were observed
throughout the gland (Fig. 4A), and these droplets produced ADPH,
WAP and β-casein based on immunohistochemical staining (Fig. 4B).
As expected, nearly all epithelial cell as well as some of the basal cells
in these alveoli stained positive for caSTAT5a(FLAG) (Fig. 4A and data
not shown), and Elf5 wasmore highly produced in those lobuloalveoli
than in uninfected control mammary ducts (Fig. 4B). Interestingly,
based on immunohistochemical staining with an antibody againsttotal STAT5, the total STAT5 in the caSTAT5a-cells did not appear to
have increased over the basal level of STAT5 detected in non-infected
control cells, but all detectable STAT5 was in the nucleus, suggesting
that even the endogenous STAT5 was activated in these differentiated
alveolar cells (Supplemental ﬁgure 5). In aggregate, activation of
STAT5a alone in mammary epithelial cells in virgin glands can induce
cell expansion, a commitment to alveolar fate, and persistent
lactogenesis.
Discussion
Our in vivo studies in intact and developed mammary glands
demonstrate that mammary epithelial cells exhibit a relatively long
half life, and that STAT5a activation suppresses their normal turnover
and causes rapid cell expansion, alveolar differentiation, and
persistent lactogenesis. Unexpectedly, the entire mammary gland
can be replaced by the progeny of approximately 0.3% of the cells that
were initially transduced with retrovirus expressing caSTAT5a.
Importantly, caSTAT5a-induced differentiation and lactogenesis do
not require ovarian functions, although the caSTAT5a-induced cell
proliferation partly depends on ovarian hormones.
Traditional studies of cell turnover in the mammary gland have
only provided the net gain or loss of all cells or a subset of cells in
whole tissue (Asselin-Labat et al., 2007; Fata et al., 2001; Kouros-Mehr
et al., 2006; Rose-Hellekant et al., 2006). There are a paucity of tools
for cell fate tracking of individual cells in intact mammary glands,
although mosaic analysis with double markers (MADM) and other
genetic recombination methods have been used to mark speciﬁc cells
in other epithelial tissues (Luo, 2007; Minami et al., 2005; Muzumdar
et al., 2007; Wang et al., 2007). Our approach provides the
opportunity to introduce genetic markers or potential cell fate
regulators into individual ductal epithelial cells, so that the cell fate
of individual cells in the context of a normal surrounding environ-
ment can be examined. With this approach, we demonstrated a slow
turnover of the ductal epithelial cell population. Of note, the MMTV
LTR, which directs the tva expression and thus the spectrum of the
cells that are susceptible to infection in our mice, is most strongly
active in differentiated ductal epithelial cells (Vargo-Gogola and
Rosen, 2007). While these more differentiated infected cells turn over
relatively quickly; the less differentiated cell population that is not
targeted by this virus may remain for a much longer time.
With this cell-tracking approach, we discovered a master role of
STAT5a activation in driving both proliferation and alveolar differenti-
ationofductal epithelial cells. These results also reveal theextraordinary
potential of ductal epithelial cells in proliferation and bipotential
differentiation into both alveolar cells and myoepithelial cells. Our
results are consistentwith previous reports concluding an essential role
for STAT5a in regulating mammary alveolar differentiation (Hennigh-
ghausen andRobinson, 2008; Yamaji et al., 2009), andwith a new report
which was published while our manuscript was under review that
transplantation of mammary cells infected by a lentivirus expressing an
activated version of STAT5 can induce alveoli-like expansion in cleared
fat pads in a virgin host (Vafaizadeh et al., 2010).
Approximately 0.3% of themammary epithelial cells are infected in
this viral system (Du et al., 2006). This pool of cells diminished over
time (based on the result using RCAS-β-actin), suggesting little
progenitor potential among them and consistent with the character-
istics of the MMTV promoter which deﬁnes the expression of tva and
thus the cells susceptible to infection. However, this small pool of
cells, after gaining caSTAT5a, expanded and replaced the entire
mammary gland after 1 year. The positive staining of caSTAT5 was
even observed in the basal layer. These data suggest that STAT5a
activation can induce a bipotential progenitor potential in this RCAS-
infected subset of relatively quiescent and differentiated mammary
ductal epithelial cells; although the infected cells were likely
heterogenous and only a subset of them might have the potential to
Fig. 4. Activation of STAT5a in adult mammary gland 1 year post infection. Twelve-week-old MMTV-tva mice (n=20) were infected with RCAS-caSTAT5a(FLAG), and euthanized
1 year later. (A) Whole mount staining, H&E staining, and immunohistochemical staining for the FLAG tag in caSTAT5a. Consecutive sections were used. Insets show a 2-fold higher
magniﬁcation of the boxed areas. (B) Immunostaining for the indicated markers. Arrows indicate lipid droplets within epithelial cells, and arrowhead indicates a lipid droplet in the
lumen.
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results are consistent with previous reports of a role of STAT5 in
regulating alveolar progenitors and stem cells (Vafaizadeh et al., 2010;
Yamaji et al., 2009), and provide a potential molecular mechanism for
the generation of the so called “parity-induced mammary cells,”which
have been found to have stem and progenitor properties (Boulanger
et al., 2004; Henry et al., 2004;Matulka et al., 2007;Wagner et al., 2002).
Alveolar cells are reported to be produced and quickly turned over
during the estrus cycle in virgin mice, and lactogenic cells undergo
involution rapidly especially after the cessation of suckling. Therefore,
it is a surprise that these caStat5-induced highly differentiated and
lactogenic cells did not disappear over time, but rather expanded and
persisted in virgin animals. This observation may be due to reported
antiapoptotic roles of STAT5a, which transcriptionally activates Bcl2
and BclXL (Dumon et al., 1999). Persistent STAT5a signaling may also
interfere with STAT3 activation, which is known to occur at the end of
lactation to cause mammary cell apoptosis through transcriptional
activation of the genes encoding suppressor of cytokine signaling 3
(Socs3) and CCAAT/enhancer binding protein delta (C/EBPδ) (Baxter
et al., 2007; Pensa et al., 2009; Li et al., 1997). Indeed, we did not
detect activated STAT3 in these infected glands by immunohisto-
chemical staining (Supplemental ﬁgure 6), and nor did we detect an
increase in the level of apoptosis over a low baseline level in the non-
infected glands based on a TUNEL assay (data not shown). However,
we do not know whether involution may activate STAT3 in these
caSTAT5a-expressing cells and cause them to undergo apoptosis if the
infected mice were allowed to progress through a reproductive cycle.Like prolactin-Jak2-STAT5 signaling, estrogen and progesterone
signaling have also been linked to both mammary cell proliferation
and differentiation. These pathways also appear to interact with each
other. For example, acute treatment of ovariectomized mice with
estrogen and progesterone has been shown to induce STAT5a
expression (Santos et al., 2008); conversely, STAT5a can induce ER
transcription (Frasor et al., 2001a,b). However, it was not previously
known whether STAT5-regulated mammary cell proliferation or
differentiation actually requires these ovarian hormones. Our results
provide strong evidence that in the absence of any ovarian function,
STAT5a activation is sufﬁcient to cause ductal epithelial cells to
undergo alveolar differentiation and lactogenesis as well as a modest
increase in cell proliferation. However, ovarian hormones can
signiﬁcantly increase the proliferative response to STAT5a activation.
Transgenic overexpression of wild-type STAT5a or an activated
version of STAT5a (which is a fusion of part of STAT5a with the
transcriptional activation domain of STAT6 and the kinase domain of
Jak2), or even a dominant-negative version of STAT5a has been
reported to occasionally cause tumors with a long latency (8–
12 months) after repeated reproductive cycles (Iavnilovitch et al.,
2004). Occasional tumors also arose after the ﬁrst or second round of
pregnancy and lactation in mice that have been transplanted with
mammary cells ex vivo infected with a lentivirus expressing STAT5a
(S711F) (Vafaizadeh et al., 2010). Only one tumor was observed in
twenty RCAS-caSTAT5a-infected mice followed for over 1 year, and at
necropsy two glands were found to have a focal hyperplasia based on
whole mount and H&E staining. The rare progression of caSTAT5a+
202 J. Dong et al. / Developmental Biology 346 (2010) 196–203cells in our study may be due to a smaller pool of STAT5a-activated
cells, a different subset of cells with STAT5a activation, a different
expression level of activated STAT5a, a different version of activated
STAT5a, or the tumor-inhibitory effects of the surrounding normal
and intact virgin ductal epithelium.
In conclusion, using a retrovirus-mediated in vivo gene expression
approach in developmentally normal mammary glands, we discov-
ered that the ductal epithelial cells in the adult virgins turned over
slowly, that STAT5a activation leads to rapid cell expansion with
concurrent alveolar differentiation and persistent lactogenesis, and
that these effects are largely independent of ovarian functions.
Materials and methods
Animals
The MMTV-tva transgenic mice (on the FVB background) have
been reported (Du et al., 2006). Animal experimentation was
approved by the Institutional Animal Care and Use Committee of
Baylor College of Medicine, and conducted under the guidelines
described in the NIH Guide for the Care and Use of Laboratory
Animals.
Plasmids
The plasmid pMX-STAT5a1*6-FLAG plasmid carrying murine
STAT5awith two activating mutations (H299R and S711F) was kindly
provided by Dr. Toshio Kitamura, University of Tokyo, Tokyo, Japan
(Onishi et al., 1998). This caSTAT5 gene alongwith its FLAG tag at its C-
terminus was released by restriction digestion with EcoRI and NotI,
blunt-ended by Klenow fragment of DNA Polymerase II and cloned
into the PmeI site of RCAS-Y, a modiﬁed version of RCASBP(A)
(Hughes, 2004). The insert sequence of this plasmid, RCAS-caSTAT5a
(FLAG), was conﬁrmed by DNA sequencing. RCAS-β-actin(HA) has
been described elsewhere (Toneff et al.).
Virus preparation and delivery to the mammary gland
DF-1 chicken ﬁbroblasts were transfected with RCAS vectors using
the Superinfect transfection reagent (Qiagen, Valencia, CA), and
maintained in DMEM supplemented with 10% FBS in 37 °C incubator
with 5% CO2. The virus supernatant was concentrated 100-fold by
centrifugation at 125,000g for 90 min. The virus pellet were
resuspended in medium and prepared as aliquot. The titer of virus
was determined by limiting dilution in DF1 cells. Virus is delivered
into mouse mammary gland by intraductal injection as described (Du
et al., 2006).
Tissue preparation, histology and whole mount
Mammary glands were removed and ﬁxed in 10% formalin at 4 °C
overnight. Tissue were embedded in parafﬁn, sectioned to 3-μm, and
stainedwith hematoxylin and eosin (H&E). For whole mount analysis,
the inguinal mammary glands were ﬁxed in acetic acid/ethanol for 2–
4 h at room temperature and stained with carmine alum.
Immunohistochemistry and immunoﬂuorescence
Immunostaining was performed on de-parafﬁned tissues sections
after antigen retrieval (simmering in 0.1 M citric acid, pH6.0, at 145 °C
for 10 min in a pressure cooker). For immunoperoxidase staining, the
Vectastain Elite ABC system (Vector Laboratories, Burlingame, CA)
was used following manufacturer's instructions. The antibodies used
were anti-HA (HA.11, 1:500, Covance), anti-FLAG (M2, 1:500, Sigma),
and anti-Ki67 (2011-11, 1:500, Novocastra). For immunoﬂuorescence
staining, the following primary antibodies were used: anti-adipophi-lin (RDI-PROGp40; 1:100; Fitzgerald Industries), anti-Ki67 (2011-11;
1:500; Novocastra), anti-FLAG (M2; 1:500; Sigma-Aldrich), anti-WAP
(H-131, 1:200, Santa Cruz Biotech), and anti-STAT5a (L-20, 1:100,
Santa Cruz Biotech). The sections were incubated with primary
antibodies 1 h at room temperature, followed by 30-min incubation
with Alexa Fluor 568 or Alexa Fluor 488-conjugated anti-rabbit
antibodies (1:500, Molecular Probes) or FITC-conjugated anti-mouse
antibodies (1:500, BD Biosciences). The slides were mounted with
Vectashield (Vector Laboratories).
TUNEL assays
Apoptotic cells were determined by the DeadEnd Fluorometric
TUNEL System (Promega). DAPI counterstain was used to visualize
nuclei. TUNEL-positive cells were scored in at least 5 ﬁelds per section.
Statistical analyses
A two-tailed Student's t test was applied for all comparisons, and p
values of 0.05 or less were deﬁned statistically signiﬁcant. Continuous
variable results were always reported as Mean±SEM for each group.
Pearson's Chi-squared test was applied for analyzing the quantiﬁca-
tion of Elf5 staining.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2010.07.027.
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